Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Share-based Compensation (2017 - 2025)

IGC Pharma has reported Share-based Compensation over the past 15 years, most recently at -$3.5 million for Q3 2025.

  • Quarterly Share-based Compensation fell 975.12% to -$3.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.0 million through Sep 2025, up 20.84% year-over-year, with the annual reading at $1.6 million for FY2025, 7.5% down from the prior year.
  • Share-based Compensation was -$3.5 million for Q3 2025 at IGC Pharma, down from $4.7 million in the prior quarter.
  • Over five years, Share-based Compensation peaked at $4.7 million in Q2 2025 and troughed at -$3.5 million in Q3 2025.
  • The 5-year median for Share-based Compensation is $455000.0 (2025), against an average of $514210.5.
  • The largest YoY upside for Share-based Compensation was 1069.15% in 2025 against a maximum downside of 975.12% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $523000.0 in 2021, then dropped by 7.46% to $484000.0 in 2022, then rose by 8.68% to $526000.0 in 2023, then dropped by 27.57% to $381000.0 in 2024, then crashed by 1023.36% to -$3.5 million in 2025.
  • Per Business Quant, the three most recent readings for IGC's Share-based Compensation are -$3.5 million (Q3 2025), $4.7 million (Q2 2025), and $455000.0 (Q1 2025).